Michigan Medicine 27th Annual Liver Disease Wrap-Up 2024

Target Audience

Overview

Experts in Hepatology from the University of Michigan Medical School will present a half-day program for physicians and other health care providers that outlines the most current treatment information for patients with liver diseases and complications. Combining case-based information, research studies, and common practice, presentations and question and answer panels will focus on challenges seen in liver care. This important update in the field of hepatology will give attendees what they need to improve patient treatment and offer better outcomes. After completing this activity, participants will use evidence-based care and therapeutic options to treat common liver conditions seen in the primary care office and will provide care following current guidelines, select appropriate tests and imaging studies, and refer patients when needed.

Objectives

1. utilize the latest developments in the diagnosis, staging and treatment of metabolic associated steatotic liver disease (MASLD).
2. identify new developments in the diagnosis and treatment of cholestatic, autoimmune and genetic liver diseases.
3. understand the recommended medical and behavioral interventions for patients with alcohol use disorder as well as current standard of care management for patients with alcohol associated hepatitis and cirrhosis.
4. implement new treatments including use of immunotherapies for hepatocellular carcinoma.
5. utilize new developments in liver transplantation including new strategies in organ preservation.